Please login to the form below

Almac group

Almac provides the most comprehensive range of services extending from research through pharmaceutical and clinical development to commercialisation of product. Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 30 years.

This is a FREE listing




Below are full profiles from other companies in this area

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

View profile

Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making connections with clients and research participants alike. Flexibility, creativity and the desire to do what is right for your business drive what we do.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

Company Details

Almac group

Telephone:+44 (0) 28 3833 2200

Address:
Almac House
20 Seagoe Industrial Estate Craigavon
BT63 5QD
United Kingdom

Latest content from PMHub

Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
Fireside Chat with Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals Impetus Digital
Live Webinar: Harnessing Technology to Improve Health and Healthcare
Fireside Chat with Steven Collens, Chief Executive Officer at MATTER Impetus Digital
Using Artificial Intelligence to Transform Pharma
In the latest episode of Impetus Digital's Fireside Chat, Natalie Yeadon sits down with Dr. Andree Bates, Founder & CEO of Eularis, and discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. Among many other interesting topics, they dissect the barriers to the adoption of "Future Tech"; their predictions for the roles that AI will play in healthcare, Pharma, and medical research within the next few years; and how AI be leveraged to improve patient-centricity. Impetus Digital
Session 4: Systems Innovation Insight and Thinking
Impetus Digital